Together, these data suggested that complotypes consisting of homozygous genotypes of fetal CD46 SNPs and heterozygous/homozygous genotypes of maternal factor H or C3 predisposed women to develop preeclampsia. This evidence concerns the gene CD46 and preeclampsia.